NCT02875613 2024-08-28
Avelumab for Recurrent/Metastatic Nasopharyngeal Cancer
University of California, San Diego
Phase 2 Terminated
Clinical Trials
5 trialsNCT02874651 2022-01-11
ADVANCE
Sun Yat-sen University
Phase 2 Terminated
NCT02706691 2019-04-16
BGJ398 in Treating Patients With FGFR Positive Recurrent Head and Neck Cancer
University of Chicago
Phase 2 Terminated
NCT00003489 2017-11-21
Antineoplaston Therapy in Treating Patients With Advanced Head and Neck Cancer
Burzynski Research Institute
Phase 2 Terminated
NCT00025298 2012-09-24
Chemotherapy Plus Radiation Therapy With or Without Amifostine in Treating Patients With Locally Advanced Cancer of the Nasopharynx
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Terminated